Google+ Facebook Twitter Twitter

Tech news: June

This month's top tech news stories


Recirculating chiller

IKA has added a new device class to its portfolio of recirculating chillers. The RC 2 lite is compact, powerful and is a perfect addition to rotary evaporators, reflux coolers and cold traps. It is a new product class in addition to the well-known basic and control product ranges. The RC 2 lite has 400 watt cooling capacity and a pump pressure of 0.35 bar: the new chiller focuses on the essentials in every respect.



TB diagnosis

LIOFeron-TB/LTBI from Menarini Diagnostics is a novel aid in the diagnosis of tuberculosis infection. It is an in vitro blood IGRA, useful in the detection of Mycobacterium tuberculosis – the bacteria causing tuberculosis (TB). The test is intended for use in conjunction with other medical and diagnostic evaluations. The LIOFeron-TB/LTBI kit is suitable to be performed on most open ELISA processors, including the DS2, allowing it to fit easily into the existing laboratory set up.




Viral vectors

ViroCell Biologics, the UK’s first clinical trial-focused viral vector manufacturer, has officially launched.

It aims to be the supplier of choice for viral vectors and gene-modified cells, to academic and corporate clients, for translational cell and gene therapies going into clinical trials.

One of the founders of ViroCell is Farzin Farzaneh, Professor of Molecular Medicine at King’s College London, and it expects to employ more than 50 professionals in the UK by the end of 2021.

Image credit | ViroCell Biologics

Related Articles

Laboratory errors in transfusion: Learning for the laboratory

Anne Lockhart, IBMS representative, and Victoria Tuckley from the Serious Hazards of Transfusion (SHOT) scheme explain their latest annual report.


CRISPR treatment for blood diseases

A collaborative team of researchers has presented preliminary data showing that a CRISPR-based gene-editing therapy for inherited blood disorders is safe and effective.

Brain cancer liquid biopsy

Early detection of brain cancer has moved one step closer, according to new research.

A new screening paradigm

Dr Eric Klein explains why a new blood test that can detect more than 50 types of cancer is set to have a huge clinical impact.